Clinical Trials Logo

Clinical Trial Summary

Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research


Clinical Trial Description

Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material.

Questionnaire information, including health history, growth and development, physical activity and family medical history information.

If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in, the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03359304
Study type Observational
Source Peking University People's Hospital
Contact Kuisheng Liu, phD
Phone +8601088324471
Email tumorcenter@163.com
Status Not yet recruiting
Phase N/A
Start date March 1, 2018
Completion date March 1, 2028

See also
  Status Clinical Trial Phase
Completed NCT04474678 - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") N/A
Recruiting NCT03406208 - Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing N/A
Completed NCT03513757 - Dexmedetomidine and Propofol for Pediatric MRI Sedation Phase 4
Completed NCT01682811 - Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) Phase 1
Recruiting NCT05779527 - Mindful Parenting - A Single Case Experimental Design Study N/A
Completed NCT02387177 - Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype N/A
Completed NCT01031901 - Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) Phase 1
Recruiting NCT03873610 - Resiliency Training in Adolescents With NF1 and NF2 N/A
Completed NCT01412892 - Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas Phase 2